| |
|
|
| Name: |
COMMODORE CAPITAL LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10153 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
35 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
MRUS |
Merus Nv |
1 |
- |
$53.33 |
$188,262,000 |
4,472,840 |
13.87% |
25,353,000 |
598,658 |
6.245 |
N/A |
|
|
NUVL |
Nuvalent, Inc. |
2 |
- |
$0.00 |
$131,557,000 |
1,855,000 |
9.69% |
4,618,000 |
233,400 |
2.65 |
N/A |
|
|
ELVN |
Enliven Therapeutics Ord Shs |
3 |
- |
$0.00 |
$92,004,000 |
4,675,000 |
6.78% |
-2,609,000 |
470,000 |
9.305 |
N/A |
|
|
SLNO |
Soleno Therapeutics Inc |
4 |
- |
$0.16 |
$82,168,000 |
1,150,000 |
6.05% |
13,619,000 |
-375,000 |
1.444 |
N/A |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
5 |
- |
$0.00 |
$78,004,000 |
2,325,000 |
5.75% |
-29,404,000 |
-415,000 |
3.088 |
N/A |
|
|
ALKS |
Alkermes Plc |
6 |
- |
$29.00 |
$64,389,000 |
1,950,000 |
4.74% |
-1,759,000 |
-350,000 |
1.062 |
Drug Delivery |
|
|
AGIO |
Agios Pharmaceuticals Inc |
7 |
New |
$35.35 |
$64,021,000 |
2,185,000 |
4.72% |
64,021,000 |
2,185,000 |
3.162 |
N/A |
|
|
PCVX |
Vaxcyte, Inc. |
8 |
- |
$0.00 |
$62,304,000 |
1,650,000 |
4.59% |
-70,719,000 |
25,000 |
1.209 |
N/A |
|
|
VERA |
Vera Therapeutics, Inc. |
9 |
- |
$0.00 |
$61,534,000 |
2,561,782 |
4.53% |
-21,295,000 |
603,182 |
4.672 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
10 |
- |
$22.11 |
$58,080,000 |
3,200,000 |
4.28% |
58,080,000 |
3,200,000 |
4.337 |
Diagnostic Substances |
|
|
SRRK |
Scholar Rock Holding Corp |
11 |
- |
$35.55 |
$56,102,000 |
1,745,000 |
4.13% |
15,043,000 |
795,000 |
2.016 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
12 |
- |
$7.41 |
$53,268,000 |
8,892,816 |
3.93% |
-409,000 |
2,011,187 |
6.817 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
13 |
- |
$15.23 |
$48,528,000 |
3,600,000 |
3.58% |
2,520,000 |
1,200,000 |
4 |
N/A |
|
|
NRIX |
Nurix Therapeutics, Inc. |
14 |
- |
$0.00 |
$47,269,000 |
3,978,907 |
3.48% |
-9,251,000 |
978,907 |
5.604 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
15 |
- |
$0.00 |
$34,046,000 |
2,367,578 |
2.51% |
-3,113,000 |
149,153 |
1.807 |
N/A |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
16 |
- |
$0.60 |
$32,078,000 |
1,988,084 |
2.36% |
-14,205,000 |
0 |
3.25 |
N/A |
|
|
PHVS |
Pharvaris N V Ord Shs |
17 |
- |
$0.00 |
$30,009,000 |
1,911,433 |
2.21% |
-6,633,000 |
0 |
0.462 |
N/A |
|
|
MNMD |
Mind Medicine |
18 |
- |
$7.08 |
$26,471,000 |
4,525,000 |
1.95% |
-3,516,000 |
216,575 |
5.557 |
N/A |
|
|
SLDB |
Solid Biosciences Inc |
19 |
New |
$4.87 |
$21,553,000 |
5,825,000 |
1.59% |
21,553,000 |
5,825,000 |
15.091 |
N/A |
|
|
DRUG |
Bright Minds Biosciences Or... |
20 |
- |
$0.00 |
$18,035,000 |
500,000 |
1.33% |
25,000 |
0 |
5.556 |
N/A |
|
|
CRDF |
Cardiff Oncology Inc |
21 |
- |
$1.22 |
$16,908,000 |
5,384,616 |
1.25% |
-6,461,000 |
0 |
15.245 |
Biotechnology |
|
|
ORKA |
Oruka Therapeutics, Inc |
22 |
- |
$12.61 |
$14,566,000 |
1,419,714 |
1.07% |
-12,962,000 |
0 |
4.057 |
Diagnostic Substances |
|
|
IKT |
Inhibikase Therapeutics, Inc. |
23 |
- |
$0.61 |
$11,704,000 |
5,344,432 |
0.86% |
-7,552,000 |
-580,568 |
52.915 |
N/A |
|
|
ORIC |
Oric Pharmaceuticals, Inc. |
24 |
- |
$0.00 |
$11,160,000 |
2,000,000 |
0.82% |
-4,980,000 |
0 |
2.835 |
N/A |
|
|
APGE |
Apogee Therapeutics, Inc. |
25 |
- |
$44.32 |
$10,834,000 |
290,000 |
0.8% |
-2,303,000 |
0 |
0.496 |
N/A |
|
|
NGNE |
Neurogene |
26 |
- |
$3.68 |
$10,832,000 |
925,000 |
0.8% |
-7,456,000 |
125,000 |
2.208 |
N/A |
|
|
TYRA |
Tyra Biosciences, Inc. |
27 |
New |
$0.00 |
$8,835,000 |
950,000 |
0.65% |
8,835,000 |
950,000 |
1.801 |
N/A |
|
|
PCSC |
Perceptive Capital Solution... |
28 |
- |
$0.00 |
$7,725,000 |
750,000 |
0.57% |
90,000 |
0 |
8.417 |
N/A |
|
|
CELC |
Celcuity Inc. |
29 |
- |
$13.04 |
$7,033,000 |
695,650 |
0.52% |
1,797,000 |
295,650 |
1.879 |
N/A |
|
|
VTGN |
Vistagen Therapeutics Inc |
30 |
- |
$2.04 |
$3,938,000 |
1,575,000 |
0.29% |
-708,000 |
0 |
5.827 |
Biotechnology |
|
|
AVTX |
Avalo Therapeutics, Inc |
31 |
- |
$0.43 |
$3,869,000 |
483,000 |
0.29% |
280,000 |
0 |
0.43 |
N/A |
|
|
ABVX |
Abivax S.A |
35 |
Closed |
$7.76 |
$0 |
0 |
0% |
-9,400,000 |
-1,284,110 |
0 |
N/A |
|
|
HLXB |
Helix Acquisition Corp. Ii |
34 |
Closed |
$10.60 |
$0 |
0 |
0% |
-5,250,000 |
-500,000 |
0 |
N/A |
|
|
NKTX |
Nkarta, Inc. |
33 |
Closed |
$0.00 |
$0 |
0 |
0% |
-876,000 |
-351,848 |
0 |
N/A |
|
|
THRD |
Third Harmonic Bio, Inc. |
32 |
Closed |
$5.42 |
$0 |
0 |
0% |
-2,446,000 |
-237,704 |
0 |
N/A |
|
